Dr. Selin Kurnaz of Massive Bio Explains the Need to Operationalize Patient Support in Precision Cancer Care
In this episode, we speak with Dr. Selin Kurnaz, CEO and cofounder of Massive Bio, who led a panel at the Precision Medicine Leadership Summit in Philadelphia. The panel discussion, Precision Medicine Clinical Trials and Novel Designs: Levering Data, ‘Omics’, AI and Policy focused on the importance of increasing patient accessibility to clinical trials, an issue that drove Dr. Kurnaz to cofound her company. Read more in our full summary and tune in to the episode here.
